Summary
The aim of the present study was to determine whether short-term appropriate insulinization of Type 1 (insulin-dependent) diabetic patients in longterm poor glycaemic control (HbA1C>9.5%) was associated with an adaptive regulation of the activity and gene expression of key proteins in muscle glycogen storage and glycolysis: glycogen synthase and phosphofructokinase, respectively. In nine diabetic patients biopsies of quadriceps muscle were taken before and 24-h after intensified insulin therapy and compared to findings in eight control subjects. Subcutaneous injections of rapid acting insulin were given at 3-h intervals to improve glycaemic control in diabetic patients (fasting plasma glucose decreased from 20.8±0.8 to 8.7±0.8 mmol/l whereas fasting serum insulin increased from 59±8 to 173±3 pmol/l). Before intensified insulin therapy, analysis of muscle biopsies from diabetic patients showed a normal total glycogen synthase ctivity but a 48% decrease (p=0.006) in glycogen synthase fractional velocity (0.1 mmol/l glucose 6-phosphate) (FV0.1) and a 45% increase (p=0.01) in the half-maximal activation constant of glycogen synthase (A0.5). The activity of phosphofructokinase and the specific mRNA and immunoreactive protein levels of both glycogen synthase and phosphofructokinase were similar in the two groups. The 2.8-fold increase in serum insulin levels and the halving of the plasma glucose level for at least 15 h were associated with a normalization of glycogen synthase fractional activity (FV0.1) and of the half-maximal activation constant (A0.5) whereas the enzyme activity of phosphofructokinase and the mRNA and protein levels of both glycogen synthase and phosphofructokinase remained normal. In conclusion: 1) Reduced allosterical activation of glycogen synthase in muscle of Type 1 diabetic patients in poor metabolic control occurs in the presence of normal total activity as well as normal immunoreactive protein mass and mRNA level of glycogen synthase. 2) Changes in serum insulin within the physiological range play no role in the short-term regulation of glycogen synthase mRNA and protein abundance in muscle from Type 1 diabetic patients.
Article PDF
Similar content being viewed by others
References
Kruszynska YT, Petranyi G, Home PD, Taylor R, Alberti KGMM (1986) Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 699–705
Del Prato S, Nosadini R, Tiengo A, et al. (1983) Insulinmediated glucose disposal in type 1 diabetes: evidence for insulin resistance. J Clin Endocrinol Metab 57: 904–910
Beck-Nielsen H, Richelsen B, Hother-Nielsen O, Heding LG, Schwartz Sørensen N (1984) Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 33: 832–837
Yki-Järvinen H, Koivisto VA (1986) Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315: 224–230
Lager I, Lönnroth P, Von Schenck H, Smith U (1983) Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. BMJ 287: 1661–1664
Nankervis A, Proietto J, Aitken P, Alford F (1984) Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia 27: 497–503
Pedersen O, Beck-Nielsen H (1987) Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 10: 516–523
Bak JF, Jacobsen UK, Jørgensen FS, Pedersen O (1989) Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training. J Clin Endocrinol Metab 69: 158–164
Pedersen O, Hjøllund E (1982) Insulin receptor binding to fat and blood cells and insulin action in fat cells from insulin-dependent diabetics. Diabetes 31: 706–715
Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39: 157–167
DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catherization. Diabetes 30: 1000–1007
Cohen P (1986) Muscle glycogen synthase. In: Boyer PD, Krebs EG (eds) The enzymes. Harcourt Brace Jovanovich Orlando San Diego New York Austin Boston London Sydney Tokyo Toronto, pp 461–497
Uyeda K (1979) Phosphofructokinase. In: Meister A (ed) Advances in enzymology and related areas of molecular biology. Vol 48. John Wiley & Sons, New York Chichester Brisbane Toronto pp 193–244
Bauer BA, Younathan ES (1984) Decreased phosphofructokinase activity in skeletal muscle of diabetic rats. Clin Physiol Biochem 2: 137–145
Katz A, Raz I, Spencer MK, Rising R, Mott DM (1991) Hyperglycemia induces accumulation of glucose in human skeletal muscle. Am J Physiol 260: R698-R703
Bak JF, Pedersen O (1990) Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol 258: E957-E963
Beutler E (1971) Phosphofructokinase. Red cell metabolism: a manual of biochemical methods. E Beutler (ed) Grune & Stratton, Inc, New York pp 42–44
Easterby JS, Qadri SS (1977) Hexokinase type II from rat skeletal muscle. Meth Enzymol 90: 11–15
Chomczynski P, Sacchi N (1986) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ana Biochem 162: 156–159
Pedersen O, Bak JF, Andersen PH, et al. (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865–870
Labarca C, Paigen K (1980) A simple rapid and sensitive DNA assay procedure. Ann Biochem Exp Med (Calcutta) 102: 344–351
McKinney M, Parkinson A (1987) A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 96: 271–278
Andersen I, Hannibal S (1983) Analytical and economical optimization of a glucose method with immobilized enzymes. J Autom Chem 5: 188–192
Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8: 260–266
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Mortensen HB (1980) Quantitative determination of hemoglobin A1C by thin layer isoelectric focusing. J Chromatogr 182: 325–333
Itaya K, Michio U (1965) Colorimetric determination of free fatty acids in biological fluids. J Lipid Res 6: 16–20
Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H (1992) Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41: 571–580
Mandarino LJ, Wright KS, Vertity LS, et al. (1987) Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase and glycogen synthase. J Clin Invest 80: 655–663
Vaag A, Hother-Nielsen O, Skøtt P, Andersen P, Richter EA, Beck-Nielsen H (1992) Effect of acute hyperglycemia on glucose metabolism in skeletal muscles in IDDM patients. Diabetes 41: 174–182
Yki-Järvinen H, Vuorinen-Markkola H, Koranyi LI, et al. (1992) Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients. J Clin Endocrinol Metab 75: 795–799
Andersen PH, Vestergaard H, Lund S, et al. (1993) The effect of intensive insulin therapy on insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes. Diab Med 10: 699–703
Rothman DL, Shulman RG, Shulman GI (1992) 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulindependent diabetes mellitus. J Clin Invest 89: 1069–1075
Villar-Palasi C (1991) Substrate specific activation by glucose 6-phosphate of the dephosphorylation of muscle glycogen synthase. Biochim Biophys Acta 1095: 261–267
Boden G, Jadali F, White J, et al. (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88: 960–966
Parker PJ, Caudwell FB, Cohen P (1983) Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation on the seven phosphoserine residues in vivo. Eur J Biochem 130: 227–234
Sheorain VS, Juhl H, Bass M, Soderling TR (1984) Effects of epinephrine, diabetes, and insulin on rabbit skeletal muscle glycogen synthase. J Biol Chem 259: 7024–7030
Dent P, Lavoinne A, Nakielny S, Caudwell FB, Watt P, Cohen P (1990) The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348: 302–308
Sheorain VS, Ramakrishna S, Benjamin WB, Soderling TR (1985) Phosphorylation of sites 3 and 2 in rabbit skeletal muscle glycogen synthase by multifunctional protein kinase (ATP-citrate lyase kinase). J Biol Chem 260: 12287–12292
Strålfors P, Hiraga A, Cohen P (1985) The protein phosphatase involved in cellular regulation: purification and characterisation of the glycogen-bound form of protein phosphatase-1 from rabbit skeletal muscle. Eur J Biochem 149: 295–303
Ingebritsen TS, Stewart AA, Cohen P (1983) The protein phosphatases involved in cellular regulation: measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. Eur J Biochem 132: 297–307
Sharma PM, Reddy GR, Vora S, Babior BM, McLachlan A (1989) Cloning and expression of a human muscle phosphofructokinase cDNA. Gene 77: 177–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vestergaard, H., Andersen, P.H., Lund, S. et al. Expression of glycogen synthase and phosphofructokinase in muscle from Type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment. Diabetologia 37, 82–90 (1994). https://doi.org/10.1007/BF00428782
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428782